Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease

Go back to Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
(NASDAQ: ACOG) Delayed: 8.90 -0.23 (2.52%)
Previous Close $9.13    52 Week High
Open $9.21    52 Week Low
Day High $9.22    P/E N/A 
Day Low $8.76    EPS
Volume 14,759